This product is intended for research use only. In vitro and in vivo studies have been conducted for research purposes. This product has been cited in a number of publications. Please see the link below to review the current peer reviewed papers:
https://www.sigmaaldrich.com/US/en/search/d047?focus=papers&page=1&perpage=30&sort=relevance&term=D047&type=citation_search
Fortfahren mit
D047
(±)-SKF-38393 hydrochloride
≥98% (HPLC), D1 dopamine receptor agonist, crystalline
Synonym(e):
(±)-1-Phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrochloride
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Packungsgröße | SKU | Verfügbarkeit | Preis |
|---|---|---|---|
| 100 mg | Warenkorb auf Verfügbarkeit prüfen | € 213,00 | |
| 500 mg | Warenkorb auf Verfügbarkeit prüfen | € 845,00 | |
| 1 g | Warenkorb auf Verfügbarkeit prüfen | € 1.160,00 |
Über diesen Artikel
Empirische Formel (Hill-System):
C16H17NO2 · HCl
CAS-Nummer:
Molekulargewicht:
291.77
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
crystalline
Quality level:
Storage condition:
desiccated, protect from light
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenProduktname
(±)-SKF-38393 hydrochloride, crystalline, ≥98% (HPLC)
Quality Level
assay
≥98% (HPLC)
form
crystalline
storage condition
desiccated, protect from light
color
white
solubility
H2O: >5 mg/mL, aqueous base: soluble (unstable)
SMILES string
Cl.Oc1cc2CCNCC(c3ccccc3)c2cc1O
InChI
1S/C16H17NO2.ClH/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11;/h1-5,8-9,14,17-19H,6-7,10H2;1H
InChI key
YEWHJCLOUYPAOH-UHFFFAOYSA-N
Gene Information
human ... DRD1(1812)
Application
(±)-SKF-38393 hydrochloride has been used as a selective D1 receptor agonist as a part of dopaminergic treatment. It has also been used to study its effect on prolactin in male baboons.
Biochem/physiol Actions
(±)-SKF-38393 is a D1 dopamine receptor agonist. It is known to promote the production of glutamate in the hippocampus.
Disclaimer
This material is hygroscopic. Air-sensitive. Light-sensitive.
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) |
| form crystalline | form solid | form solid | form solid |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| solubility H2O: >5 mg/mL, aqueous base: soluble (unstable) | solubility H2O: >5 mg/mL | solubility DMSO: >20 mg/mL, H2O: insoluble | solubility H2O: 1.7 mg/mL, DMSO: >10 mg/mL, ethanol: 6.3 mg/mL |
| storage condition desiccated, protect from light | storage condition desiccated, protect from light | storage condition - | storage condition desiccated |
| Gene Information human ... DRD1(1812) | Gene Information human ... DRD1(1812) | Gene Information human ... DRD1(1812) | Gene Information human ... DRD1(1812) |
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Stimulation of dopamine D1 receptor improves learning capacity in cooperating cleaner fish
Messias JPM, et al.
Proc. Royal Soc. Lond. B., 283(1823), 20152272-20152272 (2016)
The D1 dopamine receptor agonist SKF-38393 stimulates the release of glutamate in the hippocampus
Bouron A and Reuter H
Neuroscience, 94(4), 1063-1070 (1999)
Dopamine disruption increases cleanerfish cooperative investment in novel client partners
Soares MC, et al.
Royal Society open science, 4(5), 160609-160609 (2017)
Global Trade Item Number
| SKU | GTIN |
|---|---|
| D047-1G | 04061825982144 |
| D047-100MG | 04061833557693 |
| D047-500MG | 04061832090054 |
-
is this crossed the preclinical studies as in invitro and invivo for parkinson's disease
1 answer-
Helpful?
-